Published online May 19, 2008
doi:10.1084/jem.20080108
The Journal of Experimental Medicine, Vol. 205, No. 6, 1261-1268
The Rockefeller University Press, 0022-1007 $30.00
© 2008 Hagemann et al.
"Re-educating" tumor-associated macrophages by targeting NF-
B
Thorsten Hagemann1,
Toby Lawrence1,
Iain McNeish2,
Kellie A. Charles1,
Hagen Kulbe1,
Richard G. Thompson1,
Stephen C. Robinson1, and
Frances R. Balkwill1
1 Centre for Cancer and Inflammation and 2 Centre for Molecular Oncology, Institute of Cancer and CR-UK Clinical Cancer Centre, Barts and The London School of Medicine and Dentistry, London EC1M 6BQ, UK
CORRESPONDENCE Thorsten Hagemann: t.hagemann{at}qmul.ac.uk
The nuclear factor
B (NF-
B) signaling pathway is important in cancer-related inflammation and malignant progression. Here, we describe a new role for NF-
B in cancer in maintaining the immunosuppressive phenotype of tumor-associated macrophages (TAMs). We show that macrophages are polarized via interleukin (IL)-1R and MyD88 to an immunosuppressive "alternative" phenotype that requires I
B kinase β–mediated NF-
B activation. When NF-
B signaling is inhibited specifically in TAMs, they become cytotoxic to tumor cells and switch to a "classically" activated phenotype; IL-12high, major histocompatibility complex IIhigh, but IL-10low and arginase-1low. Targeting NF-
B signaling in TAMs also promotes regression of advanced tumors in vivo by induction of macrophage tumoricidal activity and activation of antitumor activity through IL-12–dependent NK cell recruitment. We provide a rationale for manipulating the phenotype of the abundant macrophage population already located within the tumor microenvironment; the potential to "re-educate" the tumor-promoting macrophage population may prove an effective and novel therapeutic approach for cancer that complements existing therapies.
T. Hagemann and T. Lawrence contributed equally to this work.
© 2008 Hagemann et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jgp.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Related Articles
-
An antiinflammatory role for IKKβ through the inhibition of "classical" macrophage activation
- Carol Ho Yan Fong, Magali Bebien, Arnaud Didierlaurent, Ruth Nebauer, Tracy Hussell, David Broide, Michael Karin, and Toby Lawrence
J. Exp. Med. 2008 205: 1269-1276.
[Abstract]
[Full Text]
[PDF]
-
IKKβ/NF-
B and the miscreant macrophage
- Anjuli M. Timmer and Victor Nizet
J. Exp. Med. 2008 205: 1255-1259.
[Abstract]
[Full Text]
[PDF]
Related In this Issue article
-
Retraining macrophages to kill tumors
- Hema Bashyam
J. Exp. Med. 2008 205: 1247.
[Full Text]
[PDF]
This article has been cited by other articles:
-
Jensen, T. O., Schmidt, H., Moller, H. J., Hoyer, M., Maniecki, M. B., Sjoegren, P., Christensen, I. J., Steiniche, T.
(2009). Macrophage Markers in Serum and Tumor Have Prognostic Impact in American Joint Committee on Cancer Stage I/II Melanoma. JCO
27: 3330-3337
[Abstract]
[Full Text]
-
Colotta, F., Allavena, P., Sica, A., Garlanda, C., Mantovani, A.
(2009). Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis
30: 1073-1081
[Abstract]
[Full Text]
-
Lepique, A. P., Daghastanli, K. R. P., Cuccovia, I. M., Villa, L. L.
(2009). HPV16 Tumor Associated Macrophages Suppress Antitumor T Cell Responses. Clin. Cancer Res.
15: 4391-4400
[Abstract]
[Full Text]
-
Oberlies, J., Watzl, C., Giese, T., Luckner, C., Kropf, P., Muller, I., Ho, A. D., Munder, M.
(2009). Regulation of NK Cell Function by Human Granulocyte Arginase. J. Immunol.
182: 5259-5267
[Abstract]
[Full Text]
-
Fingleton, B.
(2009). Tissue-Specific Regulation of Cancer Development by Immune Cells and Their Mediators. aacredbook
2009: 149-152
[Full Text]
-
Sangaletti, S., Colombo, M. P.
(2009). Macrophages Orchestrate the Tumor Microenvironment. aacredbook
2009: 209-214
[Full Text]
-
Hagemann, T., Biswas, S. K., Lawrence, T., Sica, A., Lewis, C. E.
(2009). Regulation of macrophage function in tumors: the multifaceted role of NF-{kappa}B. Blood
113: 3139-3146
[Abstract]
[Full Text]
-
Mylonas, K. J., Nair, M. G., Prieto-Lafuente, L., Paape, D., Allen, J. E.
(2009). Alternatively Activated Macrophages Elicited by Helminth Infection Can Be Reprogrammed to Enable Microbial Killing. J. Immunol.
182: 3084-3094
[Abstract]
[Full Text]
-
Ojalvo, L. S., King, W., Cox, D., Pollard, J. W.
(2009). High-Density Gene Expression Analysis of Tumor-Associated Macrophages from Mouse Mammary Tumors. Am. J. Pathol.
174: 1048-1064
[Abstract]
[Full Text]
-
Karan, D., Holzbeierlein, J., Thrasher, J. B.
(2009). Macrophage Inhibitory Cytokine-1: Possible Bridge Molecule of Inflammation and Prostate Cancer. Cancer Res.
69: 2-5
[Abstract]
[Full Text]
-
Galvez, A. S., Duran, A., Linares, J. F., Pathrose, P., Castilla, E. A., Abu-Baker, S., Leitges, M., Diaz-Meco, M. T., Moscat, J.
(2009). Protein Kinase C{zeta} Represses the Interleukin-6 Promoter and Impairs Tumorigenesis In Vivo. Mol. Cell. Biol.
29: 104-115
[Abstract]
[Full Text]
-
Mantovani, A.
(2009). Cancer-related Inflammation: The Seventh Hallmark of Cancer. Am Soc Clin Oncol Ed Book
2009: 723-726
[Abstract]
[Full Text]
-
Poupot, M., Fournie, J.-J., Poupot, R.
(2008). Trogocytosis and killing of IL-4-polarized monocytes by autologous NK cells. J. Leukoc. Biol.
84: 1298-1305
[Abstract]
[Full Text]
-
Foley, J. F., VanHook, A. M.
(2008). Science Signaling Podcast: 15 July 2008. Sci Signal
1: pc6-pc6
[Abstract]
[Full Text]
-
Fong, C. H. Y., Bebien, M., Didierlaurent, A., Nebauer, R., Hussell, T., Broide, D., Karin, M., Lawrence, T.
(2008). An antiinflammatory role for IKK{beta} through the inhibition of "classical" macrophage activation. JEM
205: 1269-1276
[Abstract]
[Full Text]